Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

8 AI strategies the White House plans to pursue, push

Paralleling its drive for greater transparency in hospital and insurer pricing, the Trump Administration is calling for AI to be made more readily understandable in all industries using it, including healthcare.

Thumbnail

Shareholders of Centene, WellCare approve merger

The shareholders of both Centene and WellCare Health Plans have approved a plan for the two companies to merge, they announced June 24. The deal is worth $17.3 billion and is expected to close in the first half of 2020.

Thumbnail

Healthcare stocks take a hit after Trump order

Healthcare stocks are reeling following an executive order from President Trump that would give HHS the ability to require hospitals and health insurance companies to provide patients with prices for healthcare services based on negotiated rates.

Thumbnail

Consumers agree insurers are to blame for surprise billing

As surprise billing solutions are more readily being talked about in Congress and among healthcare leaders in the industry, Americans are blaming their insurance companies for the problem, according to a recent survey from Morning Consult and the American College of Emergency Physicians.

Thumbnail

AI-powered pharma supply chain solution launches

Healthcare improvement company Premier has teamed up with a cognitive supply chain company, Pensiamo, to tackle drug supply chain with a new AI-powered solution.

International drug pricing index plan sent to White House

HHS has sent its proposal to base certain drug prices on an international index to the White House last week, according to a report from The Hill.

Thumbnail

Drugmakers to merge in $63B deal

Two major, global pharmaceutical companies ––AbbVie and Allergan––are merging in a deal worth approximately $63 billion.

Thumbnail

3 key points to consider before further advancing AI, big data in healthcare

A multidisciplinary task force of 14 European AI experts has come up with a set of broad guidelines for anyone using the technology to analyze big data in healthcare.

Displaying 2585 - 2592 of 6654

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup